Regulatory News
Tuesday, December 20, 2016
BRIEF-Kiadis Pharma provides update on second dose trial with ATIR101
* Kiadis Pharma provides update on second dose trial
(CR-AIR-008) with ATIR101
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment